ALPHA TEKNOVA, INC.
In Vitro & In Vivo Diagnostic Substances- 売上
- $41m
- 時価総額
- $273m
株価 $5.09 · 100株 509円
| 期 | 23/12 | 24/12 | 25/12 |
|---|---|---|---|
| 売上 | $37m | $38m | $41m |
| 成長率 | — | 2.9% | 7.4% |
| 総利益 | $10m | $7m | $13m |
| 総利益率 | 28.1% | 19.2% | 33.2% |
| 販管費 | $9m | $6m | $7m |
| 販管費率 | 25.4% | 16.7% | 16.7% |
| 営利 | ▲$36m | ▲$26m | ▲$17m |
| 営利率 | ▲96.9% | ▲69.3% | ▲41.9% |
| 純利益 | ▲$37m | ▲$27m | ▲$17m |
| PBR | 3.0 | 3.3 | 4.0 |
| PSR | 7.4 | 7.2 | 6.7 |
| PGPR | 26.5 | 37.7 | 20.3 |
| PER | — | — | — |
| ネットキャッシュ | $15m | ▲$10m | ▲$7m |
| EV/EBITDA | — | — | — |
| Rule of 40 | — | ▲66% | ▲35% |
| セールス効率 | — | — | 1,444% |
※Rule of 40は売上成長率+営業利益率、セールス効率は売上総利益増加÷販管費増加(販管費増のときのみ)
